Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
Clinical trial NCT02379091 · COMPLETED
Trial details
- NCT number
- NCT02379091
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2016-05-11
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.